Q2 2022 Regenxbio Inc Earnings Call Transcript
Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Second Quarter 2022 REGENXBIO Inc. Earnings Conference Call. (Operator Instructions). At this time, I would like to turn the conference over to Mr. Vit Vasista, Chief Financial Officer, REGENXBIO. Sir, please begin.
Good afternoon, and thank you for joining us today. With us today are Ken Mills, REGENXBIO's President and Chief Executive Officer, and Dr. Steve Pakola, our Chief Medical Officer.
Earlier this afternoon, REGENXBIO released financial and operating results for the second quarter ended June 30, 2022. The press release reporting our financial results is available on our website at www.regenxbio.com.
Today's conference call will include forward-looking statements regarding our financial outlook in addition to regulatory and product development plans. These forward-looking statements are subject to risks and uncertainties that may cause
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |